1) Block of pulmonary vessels
肺血管阻断
2) pulmonary vascular resistance
肺血管阻力
1.
Correlations of preoperative HGB,HCT and SpO_2 with pulmonary vascular resistance in patients pending two-stage Fontan procedure;
二期Fontan术术前HGB、HCT和SpO_2与肺血管阻力的相关性
2.
Objective To investigate the relationship among pulmonary vascular resistance(Rp),Pp/Ps ratio,Qp/Qs ratio and Rp/Ps ratio.
目的观察先天性心脏病术前肺血管阻力(Rp)、肺动脉/体循环压(Pp/Ps)、肺循环/体循环血流(Qp/Qs)比值与术中肺/体循环压力比值(Rp/Ps)间的关系,评估Rp对术中肺动脉高压危象的预测作用,及其对术中应用一氧化氮(NO)的指征作用。
3) vascular-disrupting
血管阻断
1.
According to the different therapeutic mechanisms, vascular-targeted therapy is divided to two groups: anti-angiogenesis approaches, aim at inhibiting new vessels formation; and vascular-disrupting approaches, designed to selectively damage or disrupt the established vessels.
根据作用机理不同,血管靶向治疗分为抗血管生成疗法(anti-angiogenesis therapy)和血管阻断疗法(vascular-disrupting therapy)。
4) vascular disrupting agents
血管阻断剂
5) four vessel occlusion
四血管阻断
1.
The VD rat model was established by four vessel occlusion(4VO).
目的 对四血管阻断大鼠血管性痴呆模型进行评价 ,为血管性痴呆的基础研究提供合适的动物模型。
6) pulmonary vascular resistance
肺循环血管阻力
补充资料：肺毛细血管静脉压
肺毛细血管静脉压
pulmonary capilla?ry pressure
正常约1.3kPa(10mmHg）。各种原因导致血容量过多；左心衰竭，排血不足，致左房舒张压增高时，均可引起肺毛血管静脉压增高出现肺水肿。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条